AllCells, LLC.    Parcell Laboratories entered into a partnership with AllCells, LLC in 2008 to offer the Parcell technology for scientific research purposes on an international basis.  AllCells provides primary human cells to the research community for "in vitro" research only. They have developed strict isolation methods to ensure that their products are of the highest purity and viability to meet the researchers needs. www.allcells.com.

Boston Biomedical Research Institute, Watertown, MA.   BBRI was founded in 1968 as an independent, nonprofit, scientific research institute dedicated to basic biomedical research to promote the prevention and treatment of a wide range of illnesses, including cancer, heart failure, stroke, diabetes, Alzheimer's and Huntington's disease.   The institute has over 100 biomedical researchers, including 27 faculty members focused on finding cures for life-debilitating and deadly diseases.  www.bbri.org.

Brigham and Women's Hospital, Inc. Boston, MA.   Parcell Laboratories has licensed from The Brigham and Women's Hospital the exclusive worldwide rights to its patent pending technology pertaining to the ELA® stem cells and their uses.

Partnership Opportunities:   Parcell Laboratories is actively pursuing partnerships, as advancement of the company's stem cell technologies can be accelerated through collaboration.  Licensing and research relationships are bound only by the limits of innovation. To inquire, please contact businessdevelopment@parcelllabs.com.